- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 103/40 - Actinides
Patent holdings for IPC class A61K 103/40
Total number of patents in this class: 45
10-year publication summary
|
0
|
2
|
1
|
2
|
3
|
0
|
5
|
5
|
7
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Algeta ASA | 15 |
3 |
| Memorial Sloan-Kettering Cancer Center | 1897 |
3 |
| Novartis Pharma AG | 92 |
2 |
| Actinium Pharmaceuticals Inc. | 134 |
2 |
| Advanced Accelerator Applications USA, Inc. | 6 |
2 |
| Bayer AS | 37 |
2 |
| Helmholtz-Zentrum Dresden-Rossendorf e.V. | 129 |
2 |
| Nihon Medi-physics Co., Ltd. | 181 |
2 |
| Advanced Accelerator Applications International S.A. | 47 |
2 |
| Novartis AG | 10974 |
1 |
| AstraZeneca UK Limited | 663 |
1 |
| Bayer Pharma AG | 1059 |
1 |
| Assistance Publique Hopitaux de Marseille | 117 |
1 |
| Cornell University | 3261 |
1 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3357 |
1 |
| Johannes Gutenberg-universitat Mainz | 133 |
1 |
| Kanagawa Prefectural Hospital Organization | 34 |
1 |
| Kyoto University | 2785 |
1 |
| NorthStar Medical Technologies, LLC | 36 |
1 |
| Perseus Proteomics Inc. | 58 |
1 |
| Other owners | 14 |